Dataset Information

Identification of USP28/NMMHC IIA-interacting proteins in endothelial cells using immunoprecipitation-coupled mass spectrometry (IP–MS)

ABSTRACT: To identify protein interaction partners of USP28/NMMHC IIA in endothelial cells, we performed immunoprecipitation-coupled mass spectrometry (IP–MS) using human umbilical vein endothelial cells (HUVECs). Cell lysates were incubated with anti-USP28/NMMHC IIA antibody, followed by pulldown using Protein A/G agarose beads. Eluted proteins were subjected to SDS denaturation, trypsin digestion, and liquid chromatography–tandem mass spectrometry (LC–MS/MS) analysis. MS analysis was carried out on a Thermo Scientific Q Exactive mass spectrometer coupled to an Easy-nLC system. High-resolution MS1 scans and HCD-based MS2 fragmentation enabled sensitive detection of immunoprecipitated proteins. Data-dependent acquisition (DDA) was applied to generate peptide spectra. Raw data were processed using MaxQuant for peptide identification against the UniProt database and label-free quantification. Database comparison and quantitative analysis revealed a set of specifically enriched proteins in the anti-USP28/NMMHC IIA IP samples.

ORGANISM(S): Homo Sapiens

SUBMITTER: Junping Kou

PROVIDER: PXD071842 | iProX | Thu Dec 11 00:00:00 GMT 2025

REPOSITORIES: iProX

ACCESS DATA

Similar Datasets

Project description:Metastasizing tumor cells exit the vascular system through dynamic interactions with endothelial cells that line the internal surface of vessels. While extravasation is a key event within the metastatic cascade, the signals regulating tumor cell adhesion to the endothelium and their subsequent transendothelial migration are poorly understood. Here, we combined Stable Isotope Labeling by Amino acids in Cell culture (SILAC) and phosphoproteomic analysis to identify cell-specific signaling pathways regulated between interacting breast cancer cells and endothelial cells (see PRIDE repository PXD001558). Further co-culture experiments were performed alongside the phosphoproteomic analysis in order to control for the protein quantity. These are presented here. Using SILAC, cell-specific labels were introduced into MDA-MB-231-LM2 cells (Human Breast cancer) and HUVECs (Human endothelial cells) to ensure each cell type had a distinct and traceable phosphoproteome when tumor and endothelial cells were co-cultured. To probe regulatory signaling events triggered in cancer cells following contact with endothelial cells, we labeled LM2 cells with medium or heavy isotopomers of arginine and lysine (Arg+6 Da, Lys+4 Da and Arg+10 Da, Lys+8 Da respectively). Heavy-labeled LM2 cells were collected by enzyme-free cell dissociation buffer, thereby preserving membrane proteins and adhesion receptors, and seeded onto a monolayer of light-labeled (Arg+0 Da, Lys+0 Da) HUVECs. Following 15 min of co-culture, non-adherent LM2 cells were gently removed and cancer cells that had attached to the endothelial layer were lysed together with the HUVECs. In parallel, medium-labeled LM2 cells were collected under the same conditions and maintained as suspension cells in monoculture to represent circulating tumor cells prior to any contact with the endothelium. These were then added to the harvested LM2-HUVEC co-culture in a 1:1 ratio of heavy:medium-labeled cells to provide a point of reference. Based on the SILAC labeling of the different cell populations, light-labeled peptides were assigned to HUVECs, medium-labeled peptides to monocultured LM2 cells in suspension, and heavy-labeled peptides to LM2 cells that had made contact with HUVECs. As such, the heavy/medium ratio for each peptide was used to quantify phosphorylation-dependent signaling changes occurring specifically in the LM2 cells upon contact with HUVECs. Conversely, to elucidate signaling events in HUVECs that were initiated by contacting cancer cells, light-labeled LM2 cells were seeded on top of a confluent monolayer of heavy-labeled HUVECs, while medium-labeled HUVECs were maintained in monoculture. Following 15 min of co-culture, the unattached LM2 cells were removed. Cells were lysed, mixed in a 1:1 ratio of heavy:medium HUVECs, followed by membrane fractionation and phosphoproteomic analysis as described above. A variation in phospho-peptide quantity could be due to the experimental difficulties in mixing heavy and medium labels in a 1:1 ratio or a quick regulation of the protein quantity through modification of its expression/degradation balance. Thus, we performed relative quantification of non-phosphorylated peptides in parallel with the phosphoproteomic analysis to account for changes in total protein abundance (data presented here) or correct for experimental bias. Cytoplasmic fractions were analyzed by LC-MS/MS before TiO2 enrichment and their median log2(H/M) were used for normalization of the phosphoproteomic dataset. In order to increase the number of proteins quantified in the LM2 cells, we performed a supplementary co-culture experiment and fractionated the peptides by SDS-PAGE. In order to get a confident relative quantification of Ephrin type-A receptor 2 (EPHA2), we performed 2 independent experiments followed by EPHA2 IP and LC-MSMS.

Dataset Information

Identification of USP28/NMMHC IIA-interacting proteins in endothelial cells using immunoprecipitation-coupled mass spectrometry (IP–MS)

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets